期刊文献+

脂蛋白肾病临床特点及载脂蛋白E基因突变检测 被引量:2

Clinical characteristics and apolipoprotein E gene mutation in patients with lipoprotein glomerulopathy
在线阅读 下载PDF
导出
摘要 目的探讨脂蛋白肾病(lipoprotein glomerulopathy,LPG)的临床病理特点,进行载脂蛋白E(apolipoprotein E,apoE)基因突变检测。方法分析10例经肾活检证实为LPG患者的临床和病理特点,对LPG患者及部分亲属进行apoE基因编码区序列测序分析。结果 10例患者均以浮肿和蛋白尿起病,均表现明显血脂紊乱,7例表现为肾病综合征,7例患者出现镜下血尿。全血DNA测序显示1例患者携带apoE基因DNA编码区C606T杂合子突变,致相应的氨基酸改变Arg158Cys;1例患者的父亲及1例患者携带apoE基因DNA编码区T468C杂合子突变,致氨基酸改变Cys112Arg。结论①本组LPG患者以青年男性居多,肾病综合征发病率高,肾脏形态偏大,血脂紊乱以总胆固醇和低密度脂蛋白增高明显。②测序结果示LPG患者少数存在编码区突变,大部分未发现apoE基因编码区突变,提示LPG发病可能存在其他遗传突变。 Objective Several mutations in apolipoprotein E gene may contribute to the pathogenesis of lipoprotein glomeru- lopathy(LPG). In this article ,we summarized the clinical features and reported the mutations of apoE gene in patients with LPG. Meth-ods Ten LPG patients and three relatives were involved in this study. The clinical and laboratory parameters of the patients were re-viewed. Coding sequences of apoE gene were sequenced after PCR amplification. Results All patients were beginning with edema and abnormal urine analysis with significant dyslipidemia. Seven patients had microscopic hematuria and seven eases bad nephrotic syn-drome. A point mutation in exon 4, C606T ( Arg158 Cys ), was found in one case ( case No. 3 ) while other point mutation in exon 4, T468 C (Cys112Arg), was found in another case (case No. 7 ) and the father of case No. 8. Conclusion In our study, there are more young male patients, high incidence of nephrotic syndrome and dyslipidemia and more large size of the kidneys. The coding region mutation of ApoE gene was only identified in two of the ten LPG patients. The results suggest that other different genetic backgrounds could be in-volved in the pathogenesis of LPG.
出处 《实用医院临床杂志》 2013年第6期57-59,共3页 Practical Journal of Clinical Medicine
关键词 脂蛋白肾病 临床表现 载脂蛋白E 基因突变 Lipoprotein glomerulopathy Clinical manifestations Apolipoprotein E Gene mutation
  • 相关文献

参考文献16

  • 1Saito T, Oikawa S, Sato H, et al. Lipoprotein glomerulopathy: renal lipidosis induced by novel apolipoprotein E variants [ J ]. Nephron, 1999,83 : 193-201.
  • 2Vasilis T, Moses E. Lipoprotein glomerulopathy [ J ]. Curr Opin Lipi- dol,2011,22:262-269.
  • 3Saito T, Ishigaki Y, Oikawa S, et al. Etiologic significance of apoli- poprotein E mutations in lipoprotein glomerulopathy [ J ]. Trend Card- iovascMed ,2002,12:67 -70.
  • 4邹玉蓉,李贵森,张萍,廖常志,王莉.脂蛋白肾病载脂蛋白E基因序列分析[J].临床肾脏病杂志,2008,8(7):303-306. 被引量:2
  • 5Ishigaki Y, Oikawa S, Suzuki T, et al. Virus-mediated transduction of apolipoprotein & Sendal develops lipoprotein glomerulopathy in apoE deficientmice [ J ]. J Biol Chem,2000,275:269-231.
  • 6Jia H, Yongli P, Yuqing C, et al. Common Apolipoprotein E Gene Mutations Contribute to Lipoprotein Glomerulopathy in China [ J ]. Nephron Clin Pract,2010,114 : c260 - c267.
  • 7罗伯殉,黄锋先,刘启才,李晓艳,关伟明,董秀清,余学清.Apolipoprotein E Guangzhou(arginine 150proline):一种新的脂蛋白肾病相关的基因突变[J].中华肾脏病杂志,2007,23(11):711-715. 被引量:3
  • 8陈姗,刘志红,郑敬民,张鑫,黎磊石.脂蛋白肾病患者载脂蛋白E基因全长序列分析[J].肾脏病与透析肾移植杂志,2005,14(3):218-223. 被引量:14
  • 9Sakatsume M, Kadomura M, Sakata I, et al. Novel glomerular Lipo- protein deposits associated with apolipoprotein E2 homozygosity[ J]. Kidney Int,2001,59 : 1911-1918.
  • 10Eto M, Watanabe K, Ishii K, et al. Aracial difference in apolipopro- tein E allele frequencies between the Japanese and caucasian popu- lations[ J]. Clin Genet, 1986,30:422.

二级参考文献32

  • 1陈燕,王庆文.全血脂蛋白吸附治疗脂蛋白肾病[J].肾脏病与透析肾移植杂志,2004,13(5):493-498. 被引量:13
  • 2ZHANGBo,LIUZhi-hong,ZENGCai-hong,ZHENGJing-min,CHENHui-ping,ZHOUHong,LILei-shi.Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy[J].Chinese Medical Journal,2005(7):555-560. 被引量:8
  • 3陈姗,刘志红,郑敬民,张鑫,黎磊石.脂蛋白肾病患者载脂蛋白E基因全长序列分析[J].肾脏病与透析肾移植杂志,2005,14(3):218-223. 被引量:14
  • 4潘永利,陈育青,张宏,李侠,邢广群,师军华,侯平,王海燕.四例脂蛋白肾病患者载脂蛋白E基因突变筛查[J].中华肾脏病杂志,2006,22(8):449-453. 被引量:13
  • 5Saito T, Sato H, Kudo K, et al. Lipoprotein glomerulopathy:glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia. Am J Kidney Dis, 1989, 13: 148-153.
  • 6Karube M, Nakabayashi K, Fujioka Y, et al. Lipoprotein glomerulopathy-like disease in a patient with type III hyperlipoproteinemia due to apolipoprotein E2. (Arg158 Cys)/3 heterozygosity. Clin Exp Nephrol, 2007, 11: 174-179.
  • 7Oikawa S, Matsunaga A, Saito T, et al. Apolipoprotein E Sendai (argi2 nine 145-proline) a new variant associated with lipop rotein glomelopathy. J Am Soc Nephrol, 1997, 8: 20-823.
  • 8Ishigaki Y, Oikawa S, Suzuki T, et al. Virus-mediated transduction of apolipoprotein & Sendai develops lipoprotein glomerulopathy in apoE deficientmice. J Biol Chem, 2000, 275 : 31,269- 231, 2731.
  • 9Matsunaga A, Sasaki J, Komatsu T, et al. A novel apolipop rotein E mutation, E2(Arg 25 Cys), in lipoprotein glomerulopathy. Kidney Int, 1999, 56:421-427.
  • 10Konishi K, Saruta T, Kuramochi S, et al. Association of a novel 3-amino acid deletion mutation of apolipop rotein E(apoE Tokyo) wity lipoprotein glomerulopahy. Nephron, 1999, 83: 214-218.

共引文献13

同被引文献33

  • 1陈燕,王庆文.全血脂蛋白吸附治疗脂蛋白肾病[J].肾脏病与透析肾移植杂志,2004,13(5):493-498. 被引量:13
  • 2陈姗,刘志红,郑敬民,张鑫,黎磊石.脂蛋白肾病患者载脂蛋白E基因全长序列分析[J].肾脏病与透析肾移植杂志,2005,14(3):218-223. 被引量:14
  • 3罗伯殉,黄锋先,刘启才,李晓艳,关伟明,董秀清,余学清.Apolipoprotein E Guangzhou(arginine 150proline):一种新的脂蛋白肾病相关的基因突变[J].中华肾脏病杂志,2007,23(11):711-715. 被引量:3
  • 4Li W, Wang Y, Han Z, et al. Apolipoprotein e mutation and double filtration plasmapheresis therapy on a new Chinese pa- tient with lipoprotein glomerulopathy[J]. Kidney Blood Press Res,2014,39(4) :330-339.
  • 5Boumendjel R, Papari M, Gonzalez M. A rare case of lipopro- tein glomerulopathy in a white man:an emerging entity in A- sia,rare in the white population[J]. Arch Pathol Lab Med, 010,134(2) : 279-282.
  • 6Saito T, Matsunaga A. Lipoprotein glomerulopathy may pro- vide a key to unlock the puzzles of renal lipidosis[J]. Kindey Int,2014,85(2) :243-245.
  • 7Oiawa S,Suzuki N, Sakuma E, et al. Abnormal lipoprotein and apolipopro-tein pattern in lipoprotein glomerulopathy[J]. Am J Kidney Dis,1991,18(5) :553-558.
  • 8Oikawa S, Matsunaga A, Saito T, et al. Apolipoprotein E Sen- dai (arginine 145--proline): a new variant associated with lipoprotein glomerulopathy [J ]. J Am Soc Nephrol, 1997, 8 (5) :820-823.
  • 9Foster K, Matsunaga A, Matalon R, et al. A rare cause of post- transplantation nephrotic syndrome [J]. Am J Kidney Dis, 2005,45(6) : 1132-1138.
  • 10Ogawa T, Maruyama K, Hattori H, et al. Anewvariant of apoli- popro-tein E(apo E Maebashi) in lipoprotein glomerulopathy[J]. PediatrNephrol, 2000,14 (2) : 149-151.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部